James Burke

Summary

Affiliation: Deaconess Billings Clinic
Country: USA

Publications

  1. doi request reprint A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer
    James M Burke
    Billings Clinic, Billings, Montana 59106, USA
    J Urol 188:2391-7. 2012
  2. doi request reprint GM-CSF-armed, replication-competent viruses for cancer
    James M Burke
    Billings Clinic, Department of Hematology and Oncology, United States
    Cytokine Growth Factor Rev 21:149-51. 2010
  3. doi request reprint Virus therapy for bladder cancer
    James Burke
    Billings Clinic, Department of Hematology and Oncology, United States
    Cytokine Growth Factor Rev 21:99-102. 2010

Collaborators

Detail Information

Publications3

  1. doi request reprint A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer
    James M Burke
    Billings Clinic, Billings, Montana 59106, USA
    J Urol 188:2391-7. 2012
    ..We assessed the safety, pharmacokinetics and anticancer activity of intravesical CG0070, a cancer selective, replication competent adenovirus, for the treatment of nonmuscle invasive bladder cancer...
  2. doi request reprint GM-CSF-armed, replication-competent viruses for cancer
    James M Burke
    Billings Clinic, Department of Hematology and Oncology, United States
    Cytokine Growth Factor Rev 21:149-51. 2010
    ..Virus based immune agents including GM-CSF armed vectors are among these early efforts. Herpes, adenovirus, and vaccinia based vectors encoding GM-CSF have reported intriguing early clinical trial results that are reviewed here...
  3. doi request reprint Virus therapy for bladder cancer
    James Burke
    Billings Clinic, Department of Hematology and Oncology, United States
    Cytokine Growth Factor Rev 21:99-102. 2010
    ..Thus far, clinical trials of virus therapy for bladder cancer have yielded mixed results. In this paper the results of several virus based clinical trials for bladder cancer are reviewed...